Alzheimer’s drug from Eli Lilly wins backing of FDA committeeThe Washington Post FDA panel votes unanimously for Eli Lilly’s Alzheimer’s treatmentYahoo Finance Alzheimer’s drug that can slow disease gets backing from FDA advisersFOX 13 Tampa Opinion | An Alzheimer’s Advance, Not a Cure-AllThe Wall Street Journal
Business
Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug – The New York Times
Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s DrugThe New York Times Opinion | An Alzheimer’s Advance, Not a Cure-AllThe Wall Street Journal FDA advisors recommend Eli Lilly’s Alzheimer’s drug donanemab, paving way for approvalCNBC FDA panel votes unanimously for Eli Lilly’s Alzheimer’s treatmentYahoo Finance
Apple unveils new AI features, Southwest Airlines pops on Elliott stake – Yahoo Finance
Apple unveils new AI features, Southwest Airlines pops on Elliott stakeYahoo Finance Activist investor takes $1.9 billion stake in Southwest Airlines, calls for leadership changesCNN Southwest Activist Fight Exposes Strains Across US Air TravelBloomberg Southwest Airlines’ stock surges after activist Elliott says it can soar 77%MarketWatch How Elliott Plans to Fix Southwest—and Boost the StockBarron’s
Exclusive | Elliott Takes Big Stake in Southwest Airlines – The Wall Street Journal
Exclusive | Elliott Takes Big Stake in Southwest AirlinesThe Wall Street Journal Elliott lands on Southwest’s runway, seeking CEO exitAxios Elliott seeks new leadership and strategy for Southwest AirlinesFinancial Times An investment firm has taken a $1.9 billion stake in Southwest Airlines and wants to oust the CEOThe Hill Elliott Disrupts CEOs’ Summer Plans With […]
Nvidia sparks chatter over possible Dow inclusion after stock split – Yahoo Finance
Nvidia sparks chatter over possible Dow inclusion after stock splitYahoo Finance These 3 obstacles lie ahead for Nvidia: AnalystYahoo Finance Goldman Sachs downplays the Nvidia stock split hype, sees little impactCNBC Nvidia’s stock split makes it look like CiscoAxios Nvidia’s Rise May Be Its Downfall: The Contrarian Case for Selling NVDA NowInvestorPlace